Question 1

How does Pega accelerate digital transformation and clinical trial operations in life sciences organisations?

Accepted Answer

Pega’s intelligent automation and AI-powered platform streamline clinical trial operations by orchestrating legacy systems and digitising workflows to reduce delays and costs. With end-to-end study management, Pega helps compress trial timelines, increase transparency, and improve patient engagement and retention. This results in faster development and delivery of therapies, enabling organisations to stay competitive and bring new indications to market more efficiently.

Question 2

What life sciences-specific features does Pega provide to ensure regulatory compliance and secure interactions?

Accepted Answer

Pega supports FDA 21 CFR Part 11 compliance with automated electronic signatures, audit trails, and modification detection logic. It provides configurable regulatory form generation tools, supports industry coding standards such as MedDRA and WHO-Drug, and enables secure, multi-factor authenticated interactions with external stakeholders, including physicians and patients. These features help maintain rigorous compliance and data security essential for life sciences operations.

Question 3

How does Pega use AI and automation to improve patient-centric care and operational efficiency in life sciences?

Accepted Answer

Pega employs AI-powered real-time decisioning and omni-channel care navigation to personalise patient experiences, optimise benefits verification, prior authorisation, and medication adherence. Its platform integrates automation to reduce administrative burdens, improve care team coordination, and accelerate revenue cycle processes. This enhances patient outcomes and operational efficiency while reducing costs across R&D, clinical trials, and commercial activities.

Useful Links

Our Services

Contact Us